James Kempson

13PUBLICATIONS
43CO-AUTHORS
Tumour immunologyBiologically active moleculesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)MicrotechnologyPowder and particle technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 01, 2026
Discovery of BMS-986449: A Potent, Selective Degrader of the Transcription Factors IKZF2 (Helios) and IKZF4 (Eos) to Target Regulatory T Cells in Solid Tumors.

|Dec 03, 2025
Desymmetrization of meso-Anhydride Enabled Enantioselective Synthesis of (-)-7-(Bromomethylene)-3-amidobicyclo[2.2.1]heptane-2-carboxamide, a Scaffold for Divergent Drug Discovery Synthesis.

Jianqing Li, Subramaniam Krishnananthan, Daniel Smith

|May 24, 2025
Discovery and Characterization of a First-in-Class LIV1-TLR7/8 Immunomodulatory Conjugate with Robust Myeloid Activation and Antitumor Activity.

Sayumi Yamazoe, Yam Poudel, Emanuela Sega

|Apr 25, 2024
Process Development of a Macrocyclic Peptide Inhibitor of PD-L1.

Subha Mukherjee, Amanda Rogers, Gardner Creech

|Apr 23, 2024
Challenges with the Synthesis of a Macrocyclic Thioether Peptide: From Milligram to Multigram Using Solid Phase Peptide Synthesis (SPPS).

James Kempson, Rulin Zhao, Joseph Pawluczyk

|Oct 27, 2021
Long-Acting Tumor-Activated Prodrug of a TGFβR Inhibitor.

Yong Zhang, Karen E Parrish, David R Tortolani

Pageof 3

Frequent Collaborators

5 joint publications

Anuradha Gupta

4 joint publications

Xiaoping Hou

4 joint publications

Martins S Oderinde

3 joint publications

Antonio Ramirez